The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N7-benzyl-3-isopropyl-N5-(piperidin-4-ylmethyl)pyrazolo[1,5-a]pyrimidine-5,7-diamine ID: ALA4519886
PubChem CID: 118329761
Max Phase: Preclinical
Molecular Formula: C22H30N6
Molecular Weight: 378.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1cnn2c(NCc3ccccc3)cc(NCC3CCNCC3)nc12
Standard InChI: InChI=1S/C22H30N6/c1-16(2)19-15-26-28-21(25-14-17-6-4-3-5-7-17)12-20(27-22(19)28)24-13-18-8-10-23-11-9-18/h3-7,12,15-16,18,23,25H,8-11,13-14H2,1-2H3,(H,24,27)
Standard InChI Key: JKCBZAYPKOXUKH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
30.8387 -7.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8387 -7.8995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5481 -8.3081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2575 -7.8995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2575 -7.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5481 -6.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9705 -6.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6770 -7.0823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3900 -6.6758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0974 -7.0894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1045 -5.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3874 -5.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8150 -5.8647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8085 -6.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5876 -6.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0772 -6.2830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5980 -5.6184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1097 -4.6264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4004 -4.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4056 -3.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1197 -2.9883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1252 -2.1678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4155 -1.7539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6987 -2.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6967 -2.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5796 -7.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8638 -8.1691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2874 -8.1830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 13 1 0
11 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
15 26 1 0
26 27 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.52Molecular Weight (Monoisotopic): 378.2532AlogP: 3.88#Rotatable Bonds: 7Polar Surface Area: 66.28Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.35CX LogP: 3.36CX LogD: 0.58Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.05
References 1. Teng Y, Lu K, Zhang Q, Zhao L, Huang Y, Ingarra AM, Galons H, Li T, Cui S, Yu P, Oumata N.. (2019) Recent advances in the development of cyclin-dependent kinase 7 inhibitors., 183 [PMID:31514062 ] [10.1016/j.ejmech.2019.111641 ] 2. Diab S, Yu M, Wang S.. (2020) CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?, 63 (14): [PMID:32150405 ] [10.1021/acs.jmedchem.9b01985 ]